Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease

F. Gutzwiller (Basel, Switzerland), K. Kostikas (Basel, Switzerland), E. Gruen (Basel, Switzerland), M. Sekharan (Hyderabad, India)

Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Gutzwiller (Basel, Switzerland), K. Kostikas (Basel, Switzerland), E. Gruen (Basel, Switzerland), M. Sekharan (Hyderabad, India). Population health impact of Indacaterol/Glycopyrronium over 4 years in chronic obstructive pulmonary disease. 1990

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: